Selleck Chemicals
Selleck Chemicals
Rat IgG2b isotype control-InVivo monoclonal antibody (Clone:LTF-2) reacts with keyhole limpet hemocyanin (KLH). Because KLH is not expressed by mammals this antibody is ideal for use as an isotype-matched control for rat IgG2b antibodies in most in vivo and in vitro applications.
More Information
Supplier Page
Selleck Chemicals
Rat IgG2b isotype control-InVivo monoclonal antibody (Clone:LTF-2) reacts with keyhole limpet hemocyanin (KLH). Because KLH is not expressed by mammals this antibody is ideal for use as an isotype-matched control for rat IgG2b antibodies in most in vivo and in vitro applications.
More Information
Supplier Page
Selleck Chemicals
Rat IgG2b isotype control-InVivo monoclonal antibody (Clone:LTF-2) reacts with keyhole limpet hemocyanin (KLH). Because KLH is not expressed by mammals this antibody is ideal for use as an isotype-matched control for rat IgG2b antibodies in most in vivo and in vitro applications.
More Information
Supplier Page
Selleck Chemicals
Rat IgG2b isotype control-InVivo monoclonal antibody (Clone:LTF-2) reacts with keyhole limpet hemocyanin (KLH). Because KLH is not expressed by mammals this antibody is ideal for use as an isotype-matched control for rat IgG2b antibodies in most in vivo and in vitro applications.
More Information
Supplier Page
Selleck Chemicals
Rauwolscine hydrochloride (Isoyohimbine, α-Yohimbine, corynanthidine) is the hydrochloride salt form of Rauwolscine, a specific and potent α2 antagonist with Ki of 12 nM.
More Information
Supplier Page
Selleck Chemicals
Ravagalimab (Anti-TNFRSF5 / CD40) is a monoclonal antibody targeting CD40. It can be used for research of Crohn’s disease. MW :146.04 KD.
More Information
Supplier Page
Selleck Chemicals
Ravagalimab (Anti-TNFRSF5 / CD40) is a monoclonal antibody targeting CD40. It can be used for research of Crohn’s disease. MW :146.04 KD.
More Information
Supplier Page
Selleck Chemicals
Ravagalimab (Anti-TNFRSF5 / CD40) is a monoclonal antibody targeting CD40. It can be used for research of Crohn’s disease. MW :146.04 KD.
More Information
Supplier Page
Selleck Chemicals
Ravoxertinib (GDC-0994) is a potent, orally available and highly selective ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1.
More Information
Supplier Page
Selleck Chemicals
Ravoxertinib (GDC-0994) is a potent, orally available and highly selective ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1.
More Information
Supplier Page
Selleck Chemicals
Ravoxertinib (GDC-0994) is a potent, orally available and highly selective ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1.
More Information
Supplier Page
Selleck Chemicals
Ravoxertinib (GDC-0994) is a potent, orally available and highly selective ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1.
More Information
Supplier Page
Selleck Chemicals
Ravoxertinib (GDC-0994) is a potent, orally available and highly selective ERK1/2 inhibitor with IC50 of 1.1 nM and 0.3 nM, respectively. Phase 1.
More Information
Supplier Page
Selleck Chemicals
Ravulizumab (Anti-Complement C5) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. MW: 145.5 KD.
More Information
Supplier Page
Selleck Chemicals
Ravulizumab (Anti-Complement C5) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. MW: 145.5 KD.
More Information
Supplier Page
Selleck Chemicals
Ravulizumab (Anti-Complement C5) is a humanized monoclonal antibody that specifically binds with high affinity to the human complement protein C5. Ravulizumab can be used for the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. MW: 145.5 KD.
More Information
Supplier Page
RBC8
5mg
| Purity Not Available
Selleck Chemicals
RBC8 is a selective inhibitor of the GTPases RalA and RalB by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases Ras and RhoA.
More Information
Supplier Page
Rbin-1
1mg
| Purity Not Available
Selleck Chemicals
Rbin-1 (Ribozinoindole-1) is a potent chemical inhibitor of eukaryotic ribosome assembly. It inhibits recombinant full-length Mdn1’s ATPase activity in vitro.
More Information
Supplier Page
Rbin-1
5mg
| Purity Not Available
Selleck Chemicals
Rbin-1 (Ribozinoindole-1) is a potent chemical inhibitor of eukaryotic ribosome assembly. It inhibits recombinant full-length Mdn1’s ATPase activity in vitro.
More Information
Supplier Page
RBN012759
25mg
| Purity Not Available
Selleck Chemicals
RBN012759
5mg
| Purity Not Available
Selleck Chemicals
RBN013209
5mg
| Purity Not Available
Selleck Chemicals
RBN013209 is a potent inhibitor of CD38 with an IC50 of 0.01-0.1 μM for human CD38. It can be used for the research of cancer.
More Information
Supplier Page
RBN013209
25mg
| Purity Not Available
Selleck Chemicals
RBN013209 is a potent inhibitor of CD38 with an IC50 of 0.01-0.1 μM for human CD38. It can be used for the research of cancer.
More Information
Supplier Page
RCGD423
5mg
| Purity Not Available
Selleck Chemicals
RCGD-423 is a modulator of Glycoprotein 130 (gp130, IL6ST, IL6-beta, CD130) signalling that regulates cartilage growth and differentiation.
More Information
Supplier Page
RCGD423
25mg
| Purity Not Available
Selleck Chemicals
RCGD-423 is a modulator of Glycoprotein 130 (gp130, IL6ST, IL6-beta, CD130) signalling that regulates cartilage growth and differentiation.
More Information
Supplier Page
RCM-1
25mg
| Purity Not Available
Selleck Chemicals
RCM-1 is a nontoxic inhibitor of Forkhead box M1 (FOXM1) that suppresses goblet cell metaplasia and prevents IL-13 and STAT6 signaling in allergen-exposed mice. RCM-1 decreases carcinogenesis and nuclear β-catenin.
More Information
Supplier Page
RCM-1
5mg
| Purity Not Available
Selleck Chemicals
RCM-1 is a nontoxic inhibitor of Forkhead box M1 (FOXM1) that suppresses goblet cell metaplasia and prevents IL-13 and STAT6 signaling in allergen-exposed mice. RCM-1 decreases carcinogenesis and nuclear β-catenin.
More Information
Supplier Page
RCM-1
100mg
| Purity Not Available
Selleck Chemicals
RCM-1 is a nontoxic inhibitor of Forkhead box M1 (FOXM1) that suppresses goblet cell metaplasia and prevents IL-13 and STAT6 signaling in allergen-exposed mice. RCM-1 decreases carcinogenesis and nuclear β-catenin.
More Information
Supplier Page
RCM-1
1g
| Purity Not Available
Selleck Chemicals
RCM-1 is a nontoxic inhibitor of Forkhead box M1 (FOXM1) that suppresses goblet cell metaplasia and prevents IL-13 and STAT6 signaling in allergen-exposed mice. RCM-1 decreases carcinogenesis and nuclear β-catenin.
More Information
Supplier Page
ReACp53
5mg
| Purity Not Available
Selleck Chemicals
ReACp53 is a cell-penetrating peptide, designed to inhibit p53 amyloid formation, resues p53 function in cancer cell lines and in organoids derived from high-grade serous ovarian carcinomas (HGSOC).
More Information
Supplier Page
ReACp53
1mg
| Purity Not Available
Selleck Chemicals
ReACp53 is a cell-penetrating peptide, designed to inhibit p53 amyloid formation, resues p53 function in cancer cell lines and in organoids derived from high-grade serous ovarian carcinomas (HGSOC).
More Information
Supplier Page
Rebamipide
50mg
| Purity Not Available
Selleck Chemicals
Rebamipide (OPC-12759,Proamipide) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [125I]BH-CCK-8S with IC50 of 37.7 μM.
More Information
Supplier Page
Selleck Chemicals
Rebamipide mofetil is an orally active prodrug of Rebamipide (OPC12759). Rebamipide induces COX-2 expression, increases PGE2 levels, and enhances gastric mucosal defense in a COX-2-dependent manner.
More Information
Supplier Page
Selleck Chemicals
Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.
More Information
Supplier Page
Selleck Chemicals
Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.
More Information
Supplier Page
Selleck Chemicals
Rebaudioside A (Stevia Extract, Reb A, Glycoside A3, Stevioside A3), an natural sweetening ingredient extracted from the stevia leaf, is used in powder or liquid form to heighten sweetening intensity and improve taste. Rebaudioside A is a steviol glycoside, α-glucosidase inhibitor with IC50 of 35.01 μg/ml.can inhibit ATP-sensitive K+-channels.
More Information
Supplier Page
Selleck Chemicals
Rebaudioside B (Reb B) is one of the minor steviol glycosides (SGs) isolated from Stevia rebaudiana and has a better taste quality than many of the major SGs.
More Information
Supplier Page
Selleck Chemicals
Rebaudioside C (Dulcoside B) belongs to the family of Steviol Glycosides. It is a natural constituent of the plant Stevia rebaudiana Bertoni and used as natural sweeteners to diabetics and others on carbohydrate-controlled diets.
More Information
Supplier Page
Selleck Chemicals
Rebaudioside D (Reb D) is one of the several glycosides (SGs) found in the leaves of Stevia rebaudiana (Bertoni) which has been identified as a potential sweetener.
More Information
Supplier Page
Selleck Chemicals
Rebaudioside M, isolated from Stevia rebaudiana Bertoni, is a natural non-caloric potential sweetener in food and beverage products.
More Information
Supplier Page
Selleck Chemicals
Selleck Chemicals
Recaticimab (Anti-PCSK9) is a humanized monoclonal antibody that targets PCSK9. It has potential application in hypercholesterolemia. MW :148.28 KD
More Information
Supplier Page
Selleck Chemicals
Recaticimab (Anti-PCSK9) is a humanized monoclonal antibody that targets PCSK9. It has potential application in hypercholesterolemia. MW :148.28 KD
More Information
Supplier Page
Selleck Chemicals
Recaticimab (Anti-PCSK9) is a humanized monoclonal antibody that targets PCSK9. It has potential application in hypercholesterolemia. MW :148.28 KD
More Information
Supplier Page
Recilisib
5mg
| Purity Not Available
Selleck Chemicals
Recilisib (ON01210, EX-RAD) is a radioprotectant that activates the activity of AKT and PI3K in cells. It has been studied as prophylactic (use prior to radiation exposure) and therapeutic (after exposure to radiation) drug.
More Information
Supplier Page
Recilisib
25mg
| Purity Not Available
Selleck Chemicals
Recilisib (ON01210, EX-RAD) is a radioprotectant that activates the activity of AKT and PI3K in cells. It has been studied as prophylactic (use prior to radiation exposure) and therapeutic (after exposure to radiation) drug.
More Information
Supplier Page
Selleck Chemicals
Red Bean Extract is extracted from Red Beans, which possess various functional properties, such as anti-diabetes, anti-aging, anti-inflammatory, anticancer, and hepatoprotective activities.
More Information
Supplier Page
Selleck Chemicals
Red Cabbages Extract is extracted from Brassica oleracea L., which helps to treat diseases not only involving dyslipidemic conditions but also oxidative stress.
More Information
Supplier Page
Selleck Chemicals
Red Ginseng Extract is derived from Red Ginseng, which can increase the human body’s anti-inflammatory and anticancer immunity.
More Information
Supplier Page